Overall safety and efficacy through 10 years of treatment with delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis

Authors
Category Primary study
JournalNeurology
Year 2020
This article has no abstract
Epistemonikos ID: 3d4a67a7d5a61cebc9d9bdcf88572c62716cf555
First added on: Feb 12, 2025